Literature DB >> 19481915

Inhibition of platelet aggregation by omega-3 polyunsaturated fatty acids is gender specific-Redefining platelet response to fish oils.

Melinda Phang1, Manohar L Garg, Andrew J Sinclair.   

Abstract

Existence of gender differences in cardiovascular disease (CVD) following long-chain omega-3 polyunsaturated fatty acid (LCn-3 PUFA) supplementation have suggested that sex hormones play a role in cardio-protection. The objective of this study was to determine gender specific responses in the efficacy of LCn-3 PUFA to inhibit platelet aggregation in vitro. Blood was analyzed for collagen-induced platelet aggregation following pre-incubation with LCn-3 PUFA in healthy adults (n=42). Eicosapentaenoic acid (EPA) was significantly more effective in reducing platelet aggregation compared with docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). When grouped by gender, this differential pattern was followed in males only. In females, DHA, DPA and EPA were all equally effective. Between group analyses (LCn-3 PUFA vs. gender) showed that both DHA and DPA were significantly less effective in males compared with females. EPA was equally effective in reducing platelet aggregation in both groups. These findings show that significant gender differences exist in platelet aggregation in response to various LCn-3 PUFA treatments.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19481915     DOI: 10.1016/j.plefa.2009.05.001

Source DB:  PubMed          Journal:  Prostaglandins Leukot Essent Fatty Acids        ISSN: 0952-3278            Impact factor:   4.006


  26 in total

1.  A short-term n-3 DPA supplementation study in humans.

Authors:  Eliza Miller; Gunveen Kaur; Amy Larsen; Su Peng Loh; Kaisa Linderborg; Harrison S Weisinger; Giovanni M Turchini; David Cameron-Smith; Andrew J Sinclair
Journal:  Eur J Nutr       Date:  2012-06-23       Impact factor: 5.614

Review 2.  (n-3) fatty acids and cardiovascular health: are effects of EPA and DHA shared or complementary?

Authors:  Dariush Mozaffarian; Jason H Y Wu
Journal:  J Nutr       Date:  2012-01-25       Impact factor: 4.798

3.  Effects of seal oil and tuna-fish oil on platelet parameters and plasma lipid levels in healthy subjects.

Authors:  Neil J Mann; Stella L O'Connell; Kylie M Baldwin; Indu Singh; Barbara J Meyer
Journal:  Lipids       Date:  2010-07-23       Impact factor: 1.880

4.  Omega-3 fatty acids and incident type 2 diabetes: the Singapore Chinese Health Study.

Authors:  Diana P Brostow; Andrew O Odegaard; Woon-Puay Koh; Sue Duval; Myron D Gross; Jian-Min Yuan; Mark A Pereira
Journal:  Am J Clin Nutr       Date:  2011-05-18       Impact factor: 7.045

5.  Screening of marine bacterial producers of polyunsaturated fatty acids and optimisation of production.

Authors:  Ahmed Abd El Razak; Alan C Ward; Jarka Glassey
Journal:  Microb Ecol       Date:  2013-11-30       Impact factor: 4.552

6.  Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.

Authors:  James F Markworth; Gunveen Kaur; Eliza G Miller; Amy E Larsen; Andrew J Sinclair; Krishna Rao Maddipati; David Cameron-Smith
Journal:  FASEB J       Date:  2016-07-26       Impact factor: 5.191

Review 7.  DHA supplementation: current implications in pregnancy and childhood.

Authors:  Lynette K Rogers; Christina J Valentine; Sarah A Keim
Journal:  Pharmacol Res       Date:  2012-12-21       Impact factor: 7.658

8.  Dietary sources, current intakes, and nutritional role of omega-3 docosapentaenoic acid.

Authors:  Oleksandr A Byelashov; Andrew J Sinclair; Gunveen Kaur
Journal:  Lipid Technol       Date:  2015-04

Review 9.  Distinguishing health benefits of eicosapentaenoic and docosahexaenoic acids.

Authors:  Fraser D Russell; Corinna S Bürgin-Maunder
Journal:  Mar Drugs       Date:  2012-11-13       Impact factor: 5.118

10.  Nutritional conditions of the novel freshwater Coccomyxa AP01 for versatile fatty acids composition.

Authors:  Marco Sebastiano Nicolò; Concetta Gugliandolo; Maria Giovanna Rizzo; Vincenzo Zammuto; Nicola Cicero; Giacomo Dugo; Salvatore Pietro Paolo Guglielmino
Journal:  J Appl Microbiol       Date:  2021-08-02       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.